LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.18 | 21.74 | 591 | 6114 | 0.0967 | 0.5007 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.18 | 21.74 | 4953 | 6114 | 0.8101 | 0.9489 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.18 | 21.74 | 9 | 6114 | 0.0015 | -0.1027 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 76.18 | 21.74 | 4601 | 6114 | 0.7525 | 0.9313 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.15 | 21.74 | 628 | 6167 | 0.1018 | 0.5110 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.15 | 21.74 | 5147 | 6167 | 0.8345 | 0.9561 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.15 | 21.74 | 11 | 6167 | 0.0018 | -0.0802 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 78.15 | 21.74 | 4827 | 6167 | 0.7826 | 0.9407 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.12 | 21.74 | 692 | 6211 | 0.1114 | 0.5283 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.12 | 21.74 | 5411 | 6211 | 0.8711 | 0.9665 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.12 | 21.74 | 9 | 6211 | 0.0014 | -0.1025 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 80.12 | 21.74 | 4991 | 6211 | 0.8035 | 0.9471 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.09 | 21.74 | 722 | 6201 | 0.1164 | 0.5365 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.09 | 21.74 | 5523 | 6201 | 0.8906 | 0.9718 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.09 | 21.74 | 7 | 6201 | 0.0011 | -0.1297 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 82.09 | 21.74 | 5190 | 6201 | 0.8369 | 0.9568 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 84.06 | 21.74 | 780 | 6152 | 0.1268 | 0.5521 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 84.06 | 21.74 | 5685 | 6152 | 0.9241 | 0.9807 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 84.06 | 21.74 | 7 | 6152 | 0.0011 | -0.1299 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 84.06 | 21.74 | 5353 | 6152 | 0.8701 | 0.9661 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 86.03 | 21.74 | 828 | 6155 | 0.1345 | 0.5634 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 86.03 | 21.74 | 5875 | 6155 | 0.9545 | 0.9886 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 86.03 | 21.74 | 13 | 6155 | 0.0021 | -0.0612 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 86.03 | 21.74 | 5545 | 6155 | 0.9008 | 0.9745 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 88.00 | 21.74 | 692 | 6081 | 0.1138 | 0.5307 | MN20160310_N01 | J22 |